PARI IN THE AMERICAS

Designed with our patients in mind, PARI products aim to provide efficient aerosol delivery and a better quality of life. PARI’s foundation is our strong clinical track record developed from years of clinical research and proven safety and efficacy with well-known nebulized medications. PARI reusable nebulizers were used in the following pivotal trials to prove safety and efficacy:

Pulmicort Respules® - AstraZeneca
TOBI®, Yupelri®, Perforomist®, Accuneb®, and Duoneb® - Mylan
Pulmozyme® - Genentech
Xopenex® and Brovana® - Sunovion

*All registered marks and trademarks belong to their respective companies